Literature DB >> 10944797

Mechanisms of immune stimulation by bacterial DNA.

D S Pisetsky1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10944797     DOI： 10.1007/s002810000021

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  49 in total

1.  Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis.

Authors:  Z Wang; J G Karras; T P Colarusso; L C Foote; T L Rothstein
Journal:  Cell Immunol       Date:  1997-09-15       Impact factor: 4.868

Review 2.  Biological aspects of cytosine methylation in eukaryotic cells.

Authors:  M Hergersberg
Journal:  Experientia       Date:  1991-12-01

Review 3.  Patterns of DNA methylation--evolutionary vestiges of foreign DNA inactivation as a host defense mechanism. A proposal.

Authors:  W Doerfler
Journal:  Biol Chem Hoppe Seyler       Date:  1991-08

4.  The influence of DNA sequence on the immunostimulatory properties of plasmid DNA vectors.

Authors:  M K Wloch; S Pasquini; H C Ertl; D S Pisetsky
Journal:  Hum Gene Ther       Date:  1998-07-01       Impact factor: 5.695

Review 5.  The other side of scavenger receptors: pattern recognition for host defense.

Authors:  M Krieger
Journal:  Curr Opin Lipidol       Date:  1997-10       Impact factor: 4.776

Review 6.  Immune activation by bacterial DNA: a new genetic code.

Authors:  D S Pisetsky
Journal:  Immunity       Date:  1996-10       Impact factor: 31.745

7.  Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide.

Authors:  J S Cowdery; N J Boerth; L A Norian; P S Myung; G A Koretzky
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

8.  Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents.

Authors:  D K Monteith; S P Henry; R B Howard; S Flournoy; A A Levin; C F Bennett; S T Crooke
Journal:  Anticancer Drug Des       Date:  1997-07

9.  Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN.

Authors:  Y Kimura; K Sonehara; E Kuramoto; T Makino; S Yamamoto; T Yamamoto; T Kataoka; T Tokunaga
Journal:  J Biochem       Date:  1994-11       Impact factor: 3.387

10.  Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.

Authors:  T Tokunaga; H Yamamoto; S Shimada; H Abe; T Fukuda; Y Fujisawa; Y Furutani; O Yano; T Kataoka; T Sudo
Journal:  J Natl Cancer Inst       Date:  1984-04       Impact factor: 13.506
View more
  10 in total

1.  Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide.

Authors:  Jen-Chih Tseng; Jing-Xing Yang; Yi-Ling Liu; Yu-Wen Su; Alan Yueh-Luen Lee; Ya-Wen Chen; Ko-Jiunn Liu; Yunping Luo; Yi-Ren Hong; Tsung-Hsien Chuang
Journal:  Cancer Immunol Immunother       Date:  2021-09-28       Impact factor: 6.630

2.  Toll-like receptor 9 and 21 have different ligand recognition profiles and cooperatively mediate activity of CpG-oligodeoxynucleotides in zebrafish.

Authors:  Da-Wei Yeh; Yi-Ling Liu; Yin-Chiu Lo; Chiou-Hwa Yuh; Guann-Yi Yu; Jeng-Fan Lo; Yunping Luo; Rong Xiang; Tsung-Hsien Chuang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

3.  A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif.

Authors:  Ekambar R Kandimalla; Lakshmi Bhagat; Fu-Gang Zhu; Dong Yu; Yan-Ping Cong; Daqing Wang; Jimmy X Tang; Jin-Yan Tang; Cathrine F Knetter; Egil Lien; Sudhir Agrawal
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

4.  Development of CpG-oligodeoxynucleotides for effective activation of rabbit TLR9 mediated immune responses.

Authors:  Tsung-Hsien Chuang; Chao-Yang Lai; Ping-Hui Tseng; Chiun-Jye Yuan; Li-Chung Hsu
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

5.  CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses.

Authors:  Da-Wei Yeh; Chao-Yang Lai; Yi-Ling Liu; Chih-Hao Lu; Ping-Hui Tseng; Chiou-Hwa Yuh; Guann-Yi Yu; Shih-Jen Liu; Chih-Hsiang Leng; Tsung-Hsien Chuang
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

Review 6.  Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.

Authors:  Chao-Yang Lai; Guann-Yi Yu; Yunping Luo; Rong Xiang; Tsung-Hsien Chuang
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

Review 7.  Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases.

Authors:  Jing-Xing Yang; Jen-Chih Tseng; Guann-Yi Yu; Yunping Luo; Chi-Ying F Huang; Yi-Ren Hong; Tsung-Hsien Chuang
Journal:  Pharmaceutics       Date:  2022-02-16       Impact factor: 6.525

Review 8.  Host-pathogen protein-nucleic acid interactions: A comprehensive review.

Authors:  Anuja Jain; Shikha Mittal; Lokesh P Tripathi; Ruth Nussinov; Shandar Ahmad
Journal:  Comput Struct Biotechnol J       Date:  2022-08-04       Impact factor: 6.155

Review 9.  Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade.

Authors:  Yu-Chen Chuang; Jen-Chih Tseng; Li-Rung Huang; Chun-Ming Huang; Chi-Ying F Huang; Tsung-Hsien Chuang
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

10.  Toll-Like Receptor 21 of Chicken and Duck Recognize a Broad Array of Immunostimulatory CpG-oligodeoxynucleotide Sequences.

Authors:  Yu-Chen Chuang; Jen-Chih Tseng; Jing-Xing Yang; Yi-Ling Liu; Da-Wei Yeh; Chao-Yang Lai; Guann-Yi Yu; Li-Chung Hsu; Chun-Ming Huang; Tsung-Hsien Chuang
Journal:  Vaccines (Basel)       Date:  2020-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.